RecruitingNot ApplicableNCT04347759

Symptom Care at Home-Heart Failure

Symptom Care at Home-Heart Failure: Developing and Piloting a Symptom Monitoring and Self-Management Coaching System for Patients With Heart Failure


Sponsor

Emory University

Enrollment

50 participants

Start Date

Feb 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to adapt a computer-interface telephonic interactive voice response system that monitors symptoms and provides real-time, self-management coaching messages based on heart failure patient-reported outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Medical diagnosis of heart failure
  • New York Heart Association (NYHA) Classification of the Stages of Heart Failure Class I - IV
  • Ability to read, understand, and speak in English
  • Will be discharged home
  • Has daily access to any type of telephone

Exclusion Criteria4

  • A score of 0 or 1-2 with an abnormally drawn clock on the Mini-Cog
  • Discharged home on hospice care
  • End-stage renal failure
  • Wait list for heart transplant

Interventions

BEHAVIORALCoaching Messages

Participants receive real-time self-management coaching messages based on the severity of their symptoms. When participants call, the IVR system will ask them about each of the selected symptoms, and the patient will report symptom presence and severity numerically with the touch-tone keypad.

BEHAVIORALAutomated Daily Monitoring

Participants report daily symptoms and symptom severity. There are three categories of severity based on a numeric scale of 1 to 3 for mild symptoms, 4 to 7 for moderate symptoms, and 8 to 10 for severe symptoms.


Locations(4)

Emory University Hospital Midtown

Atlanta, Georgia, United States

Emory Clinic

Atlanta, Georgia, United States

Emory University Hospital

Atlanta, Georgia, United States

University of Utah Health

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04347759


Related Trials